Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Before Rasburicase Use for Tumor Lysis Syndrome

Am J Ther. 2023 Sep-Oct;30(5):e465-e467. doi: 10.1097/MJT.0000000000001597. Epub 2023 Jan 12.
No abstract available

MeSH terms

  • Glucosephosphate Dehydrogenase Deficiency* / complications
  • Glucosephosphate Dehydrogenase Deficiency* / diagnosis
  • Gout Suppressants / therapeutic use
  • Humans
  • Tumor Lysis Syndrome* / diagnosis
  • Tumor Lysis Syndrome* / etiology
  • Urate Oxidase / adverse effects

Substances

  • rasburicase
  • Urate Oxidase
  • Gout Suppressants